TY - JOUR
T1 - Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients
T2 - A case control study
AU - Bekkering, Frank C.
AU - Neumann, Avidan U.
AU - Brouwer, Johannes T.
AU - Levi-Drummer, Rachel S.
AU - Schalm, Solko W.
PY - 2001/12/13
Y1 - 2001/12/13
N2 - Background: High dose interferon induction treatment of hepatitis C viral infection blocks viral production over 95%. Since dose reduction is often performed due to clinical considerations, the effect of dose reduction on hepatitis C virus kinetics was studied. Methods: A new model that allowed longitudinal changes in the parameters of viral dynamics was used in a group of genotype-1 patients (N = 15) with dose reduction from 10 to 3 million units of interferon daily in combination with ribavirin, in comparison to a control group (N = 9) with no dose reduction. Results: Dose reduction gave rise to a complex viral kinetic pattern, which could be only explained by a decrease in interferon effectiveness in blocking virion production. The benefit of the rapid initial viral decline following the high induction dose is lost after dose reduction. In addition, in some patients also the second phase viral decline slope, which is highly predictive of success of treatment, was impaired by the dose reduction resulting in smaller percentage of viral clearance in the dose reduction group. Conclusions: These findings, while explaining the failure of many induction schedules, suggest that for genotype-1 patients induction therapy should be continued till HCVRNA negativity in serum in order to increase the sustained response rate for chronic hepatitis C.
AB - Background: High dose interferon induction treatment of hepatitis C viral infection blocks viral production over 95%. Since dose reduction is often performed due to clinical considerations, the effect of dose reduction on hepatitis C virus kinetics was studied. Methods: A new model that allowed longitudinal changes in the parameters of viral dynamics was used in a group of genotype-1 patients (N = 15) with dose reduction from 10 to 3 million units of interferon daily in combination with ribavirin, in comparison to a control group (N = 9) with no dose reduction. Results: Dose reduction gave rise to a complex viral kinetic pattern, which could be only explained by a decrease in interferon effectiveness in blocking virion production. The benefit of the rapid initial viral decline following the high induction dose is lost after dose reduction. In addition, in some patients also the second phase viral decline slope, which is highly predictive of success of treatment, was impaired by the dose reduction resulting in smaller percentage of viral clearance in the dose reduction group. Conclusions: These findings, while explaining the failure of many induction schedules, suggest that for genotype-1 patients induction therapy should be continued till HCVRNA negativity in serum in order to increase the sustained response rate for chronic hepatitis C.
UR - http://www.scopus.com/inward/record.url?scp=2942590371&partnerID=8YFLogxK
U2 - 10.1186/1471-230X-1-14
DO - 10.1186/1471-230X-1-14
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 11801193
AN - SCOPUS:2942590371
SN - 1471-230X
VL - 1
JO - BMC Gastroenterology
JF - BMC Gastroenterology
M1 - 14
ER -